- Home
- OTLK vs GWRS Comparison
OTLK vs GWRS Comparison
Compare OTLK & GWRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OTLK | GWRS |
|---|---|---|
| Founded | 2010 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.6M | 218.6M |
| IPO Year | 2016 | 2008 |
Fundamental Metrics
Financial Performance| Metric | OTLK | GWRS |
|---|---|---|
| Price | $0.64 | $9.09 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $2.50 | ★ $9.20 |
| AVG Volume (30 Days) | ★ 21.3M | 107.7K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 4.22% |
| EPS Growth | ★ 55.91 | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | $8,146,123.00 | ★ $41,914,000.00 |
| Revenue This Year | $1,430.98 | $15.29 |
| Revenue Next Year | $173.23 | $8.28 |
| P/E Ratio | ★ N/A | $113.88 |
| Revenue Growth | N/A | ★ 8.51 |
| 52 Week Low | $0.16 | $6.55 |
| 52 Week High | $2.54 | $11.17 |
Technical Indicators
Market Signals| Indicator | OTLK | GWRS |
|---|---|---|
| Relative Strength Index (RSI) | 32.63 | 69.92 |
| Support Level | $0.19 | $8.42 |
| Resistance Level | $0.94 | $9.31 |
| Average True Range (ATR) | 0.07 | 0.33 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 8.15 | 83.68 |
Price Performance
Historical ComparisonAbout OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About GWRS Global Water Resources Inc.
Global Water Resources Inc operates as a water resources management company that owns, operates, and manages water, wastewater, and recycled water utilities in strategically located communities, principally in metropolitan Phoenix and Tucson, Arizona. It operates within the State of Arizona. Operating revenue of the company is derived from regulated water, wastewater, and recycled water service provided to customers based upon tariff rates.